Sartorius Stedim Biotech SA (PA:DIM) — Stock Price

€181.40 EUR
▲ 1.97% today

Sartorius Stedim Biotech SA (PA:DIM) is currently trading at €181.40 EUR, up 1.97% today. Over the past 52 weeks, shares have ranged between €151.50 and €223.00. This page tracks Sartorius Stedim Biotech SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Sartorius Stedim Biotech SA.

Sartorius Stedim Biotech SA (DIM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Sartorius Stedim Biotech SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Sartorius Stedim Biotech SA Income Statement — Revenue, Profit & Earnings by Year

Sartorius Stedim Biotech SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €2.97 Billion €2.78 Billion €2.78 Billion €3.49 Billion €2.89 Billion
Cost of Revenue €1.62 Billion €1.57 Billion €1.54 Billion €1.66 Billion €1.33 Billion
Gross Profit €1.35 Billion €1.21 Billion €1.23 Billion €1.82 Billion €1.55 Billion
Research & Development €133.10 Million €144.10 Million €129.50 Million €132.40 Million €110.49 Million
SG&A €661.30 Million €168.70 Million €167.10 Million €154.70 Million €126.12 Million
Total Operating Expenses €796.30 Million €836.10 Million €749.00 Million €764.10 Million €640.34 Million
Operating Income €549.00 Million €370.60 Million €484.50 Million €1.10 Billion €912.67 Million
EBITDA €867.10 Million €670.50 Million €755.70 Million €1.33 Billion €811.96 Million
EBIT €549.00 Million €368.80 Million €518.10 Million €1.15 Billion €670.40 Million
Interest Expense €152.70 Million €158.90 Million €121.10 Million €41.00 Million €23.68 Million
Income Before Tax €373.20 Million €219.20 Million €401.10 Million €1.13 Billion €646.72 Million
Income Tax Expense €107.30 Million €40.70 Million €89.00 Million €250.50 Million €232.41 Million
Net Income €265.60 Million €175.10 Million €309.70 Million €876.10 Million €414.40 Million

Sartorius Stedim Biotech SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Sartorius Stedim Biotech SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €8.02 Billion €8.26 Billion €7.74 Billion €5.07 Billion €3.95 Billion
Total Current Assets €1.44 Billion €1.74 Billion €1.42 Billion €1.67 Billion €1.46 Billion
Cash & Equivalents
Short-term Investments €8.10 Million €9.90 Million €9.50 Million €25.90 Million €13.72 Million
Net Receivables €227.30 Million €266.80 Million €293.70 Million €418.60 Million €356.00 Million
Inventory €690.90 Million €684.90 Million €882.40 Million €1.02 Billion €782.95 Million
Property, Plant & Equipment €808.00 Million €640.24 Million
Goodwill €2.88 Billion €2.91 Billion €2.85 Billion €1.14 Billion €820.70 Million
Total Liabilities €3.89 Billion €4.23 Billion €5.07 Billion €2.55 Billion €2.22 Billion
Total Current Liabilities €1.41 Billion €938.80 Million €937.30 Million €1.04 Billion €1.04 Billion
Long-term Debt €1.87 Billion €2.68 Billion €3.51 Billion €1.02 Billion €521.07 Million
Net Debt €2.32 Billion €2.19 Billion €3.57 Billion €1.03 Billion €401.89 Million
Total Stockholder Equity €4.09 Billion €3.99 Billion €2.64 Billion €2.45 Billion €1.66 Billion
Retained Earnings €2.70 Billion €2.50 Billion €2.39 Billion €2.18 Billion €1.40 Billion

Sartorius Stedim Biotech SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Sartorius Stedim Biotech SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €538.60 Million €815.10 Million €746.40 Million €612.30 Million €695.97 Million
Capital Expenditures €393.20 Million €339.80 Million €473.60 Million €430.60 Million €323.99 Million
Free Cash Flow €145.40 Million €475.30 Million €156.10 Million €181.70 Million €695.97 Million
Investing Cash Flow €-397.70 Million €-340.00 Million €-2.72 Billion €-957.50 Million €-465.23 Million
Financing Cash Flow €-389.20 Million €84.90 Million €1.99 Billion €220.70 Million €-71.71 Million
Dividends Paid €67.10 Million €67.10 Million €132.70 Million €116.10 Million €62.68 Million
Stock-Based Compensation €900.00K
Depreciation €318.10 Million €301.70 Million €237.60 Million €181.70 Million €141.56 Million
Change in Cash €-252.80 Million €562.30 Million €9.50 Million €-116.50 Million €163.86 Million

Sartorius Stedim Biotech SA Earnings History — EPS Actual vs. Analyst Estimates

Track Sartorius Stedim Biotech SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 23, 2026 1.27
Apr 22, 2026 1.17 1.21 -3.31%
Feb 02, 2026 1.12 1.30 -13.85%
Oct 15, 2025 0.94 1.01 -6.93%
Jul 22, 2025 1.18 1.05 +12.38%
Apr 15, 2025 1.16 0.94 +23.40%
Jan 27, 2025 1.03 1.02 +0.98%
Oct 17, 2024 0.76 0.84 -9.52%